Bios Capital Management, LP Portfolio Holdings

Bios Capital Management, LP

  • $88.9 Billion
  • Q3 2025

Bios Capital Management, LP has filed its 13F form on November 12, 2025 for Q3 2025 where it was disclosed a total value porftolio of $88.9 Billion distributed in 9 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Actuate Therapeutics Inc with a value of $67.2B, Cognition Therapeutics Inc with a value of $8.1B, Ocuphire Pharma, Inc. with a value of $6.59B, Lantern Pharma Inc. with a value of $4.42B, and Rein Therapeutics Inc with a value of $1.94B.

Examining the 13F form we can see an increase of $16.3B in the current position value, from $72.6B to 88.9B.

Bios Capital Management, LP is based out at Fort Worth, TX

Below you can find more details about Bios Capital Management, LP portfolio as well as his latest detailed transactions.

Portfolio value $88.9 Billion
Healthcare: $19.7 Billion

Stock Holdings Table ETFs Only

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 9
  • Current Value $88.9 Billion
  • Prior Value $72.6 Billion
  • Filing
  • Period Q3 2025
  • Filing Date November 12, 2025
  • Form Type 13F-HR
  • Activity in Q3 2025
  • New Purchases 0 stocks
  • Additional Purchases 1 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 1 stocks
Track This Portfolio

Track Bios Capital Management, LP Portfolio

Follow Bios Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bios Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bios Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email